List of Excipients in API nicotine polacrilex lozenge 2 mg
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing nicotine polacrilex lozenge 2 mg
Detailed excipient profiles for nicotine polacrilex lozenge 2 mg
Excipient focus: ACACIA
nicotine polacrilex lozenge 2 mg drug variants containing ACACIA
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 |
Chain Drug Marketing Association INC | nicotine polacrilex lozenge 2 mg | 63868-733 |
>Company | >Ingredient | >NDC |
nicotine polacrilex lozenge 2 mg drug variants not containing ACACIA
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
nicotine polacrilex lozenge 2 mg drug variants containing GLYCERIN
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 |
Chain Drug Marketing Association INC | nicotine polacrilex lozenge 2 mg | 63868-733 |
>Company | >Ingredient | >NDC |
nicotine polacrilex lozenge 2 mg drug variants not containing GLYCERIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
nicotine polacrilex lozenge 2 mg drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 |
Chain Drug Marketing Association INC | nicotine polacrilex lozenge 2 mg | 63868-733 |
>Company | >Ingredient | >NDC |
nicotine polacrilex lozenge 2 mg drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
nicotine polacrilex lozenge 2 mg drug variants containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 |
Chain Drug Marketing Association INC | nicotine polacrilex lozenge 2 mg | 63868-733 |
>Company | >Ingredient | >NDC |
nicotine polacrilex lozenge 2 mg drug variants not containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MENTHA ARVENSIS LEAF OIL
nicotine polacrilex lozenge 2 mg drug variants containing MENTHA ARVENSIS LEAF OIL
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 |
Chain Drug Marketing Association INC | nicotine polacrilex lozenge 2 mg | 63868-733 |
>Company | >Ingredient | >NDC |
nicotine polacrilex lozenge 2 mg drug variants not containing MENTHA ARVENSIS LEAF OIL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MENTHOL
nicotine polacrilex lozenge 2 mg drug variants containing MENTHOL
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 |
Chain Drug Marketing Association INC | nicotine polacrilex lozenge 2 mg | 63868-733 |
>Company | >Ingredient | >NDC |
nicotine polacrilex lozenge 2 mg drug variants not containing MENTHOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: PEPPERMINT OIL
nicotine polacrilex lozenge 2 mg drug variants containing PEPPERMINT OIL
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 |
Chain Drug Marketing Association INC | nicotine polacrilex lozenge 2 mg | 63868-733 |
>Company | >Ingredient | >NDC |
nicotine polacrilex lozenge 2 mg drug variants not containing PEPPERMINT OIL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLACRILIN
nicotine polacrilex lozenge 2 mg drug variants containing POLACRILIN
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 |
Chain Drug Marketing Association INC | nicotine polacrilex lozenge 2 mg | 63868-733 |
>Company | >Ingredient | >NDC |
nicotine polacrilex lozenge 2 mg drug variants not containing POLACRILIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM BICARBONATE
nicotine polacrilex lozenge 2 mg drug variants containing POTASSIUM BICARBONATE
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 |
Chain Drug Marketing Association INC | nicotine polacrilex lozenge 2 mg | 63868-733 |
>Company | >Ingredient | >NDC |
nicotine polacrilex lozenge 2 mg drug variants not containing POTASSIUM BICARBONATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM ALGINATE
nicotine polacrilex lozenge 2 mg drug variants containing SODIUM ALGINATE
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 |
Chain Drug Marketing Association INC | nicotine polacrilex lozenge 2 mg | 63868-733 |
>Company | >Ingredient | >NDC |
nicotine polacrilex lozenge 2 mg drug variants not containing SODIUM ALGINATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM CARBONATE
nicotine polacrilex lozenge 2 mg drug variants containing SODIUM CARBONATE
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 |
Chain Drug Marketing Association INC | nicotine polacrilex lozenge 2 mg | 63868-733 |
>Company | >Ingredient | >NDC |
nicotine polacrilex lozenge 2 mg drug variants not containing SODIUM CARBONATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
nicotine polacrilex lozenge 2 mg drug variants containing SUCRALOSE
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 |
Chain Drug Marketing Association INC | nicotine polacrilex lozenge 2 mg | 63868-733 |
>Company | >Ingredient | >NDC |
nicotine polacrilex lozenge 2 mg drug variants not containing SUCRALOSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
nicotine polacrilex lozenge 2 mg drug variants containing TRIACETIN
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 |
Chain Drug Marketing Association INC | nicotine polacrilex lozenge 2 mg | 63868-733 |
>Company | >Ingredient | >NDC |
nicotine polacrilex lozenge 2 mg drug variants not containing TRIACETIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: XANTHAN GUM
nicotine polacrilex lozenge 2 mg drug variants containing XANTHAN GUM
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Inc | nicotine polacrilex lozenge 2 mg | 43598-986 |
Chain Drug Marketing Association INC | nicotine polacrilex lozenge 2 mg | 63868-733 |
>Company | >Ingredient | >NDC |
nicotine polacrilex lozenge 2 mg drug variants not containing XANTHAN GUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.